Kala Bio Inc (KALA)
6.52
+0.12
(+1.88%)
USD |
NASDAQ |
Apr 25, 12:19
Kala Bio Total Liabilities (Quarterly): 48.44M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 48.44M |
| September 30, 2023 | 49.90M |
| June 30, 2023 | 49.01M |
| March 31, 2023 | 48.76M |
| December 31, 2022 | 67.85M |
| September 30, 2022 | 86.67M |
| June 30, 2022 | 116.53M |
| March 31, 2022 | 116.86M |
| December 31, 2021 | 122.62M |
| September 30, 2021 | 132.34M |
| June 30, 2021 | 131.19M |
| March 31, 2021 | 120.04M |
| December 31, 2020 | 121.61M |
| September 30, 2020 | 119.07M |
| June 30, 2020 | 116.57M |
| Date | Value |
|---|---|
| March 31, 2020 | 117.02M |
| December 31, 2019 | 124.63M |
| September 30, 2019 | 117.96M |
| June 30, 2019 | 117.75M |
| March 31, 2019 | 114.65M |
| December 31, 2018 | 115.99M |
| September 30, 2018 | 29.14M |
| June 30, 2018 | 27.50M |
| March 31, 2018 | 24.72M |
| December 31, 2017 | 26.87M |
| September 30, 2017 | 24.83M |
| June 30, 2017 | 136.01M |
| March 31, 2017 | 15.14M |
| December 31, 2016 | 134.09M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
48.44M
Minimum
Dec 2023
132.34M
Maximum
Sep 2021
101.31M
Average
117.02M
Median
Mar 2020
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 16.06M |
| AIM ImmunoTech Inc | 9.147M |
| IGC Pharma Inc | 2.206M |
| NovaBay Pharmaceuticals Inc | 5.72M |
| Protalix BioTherapeutics Inc | 50.86M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 55.95M |
| Shareholders Equity (Quarterly) | 7.504M |